PURPOSE: To examine the relationship of serum and dietary magnesium (Mg) with incident hypertension. The setting was the Atherosclerosis Risk in Communities (ARIC) Study, which included a biracial cohort, aged 45-64 years, from four U.S. communities. METHODS: This analysis included 7731 participants (4190 women and 3541 men) free of hypertension at baseline and followed six years. Fasting serum Mg was measured, and usual dietary intake was assessed with a food frequency questionnaire. RESULTS: After adjustment for age, race, and a number of other risk factors, the odds of incident hypertension across ascending quartiles of serum Mg were 1.0, 0.79, 0.85, and 0.70 in women (p trend = 0.01) and 1.0, 0.87, 0.87, and 0.82 in men (p trend = 0.16). We found no association between dietary Mg intake and incident hypertension. These associations were attenuated after the addition of baseline systolic blood pressure to the models. CONCLUSIONS: This study suggests that low Mg may play a modest role in the development of hypertension.
PURPOSE: To examine the relationship of serum and dietary magnesium (Mg) with incident hypertension. The setting was the Atherosclerosis Risk in Communities (ARIC) Study, which included a biracial cohort, aged 45-64 years, from four U.S. communities. METHODS: This analysis included 7731 participants (4190 women and 3541 men) free of hypertension at baseline and followed six years. Fasting serum Mg was measured, and usual dietary intake was assessed with a food frequency questionnaire. RESULTS: After adjustment for age, race, and a number of other risk factors, the odds of incident hypertension across ascending quartiles of serum Mg were 1.0, 0.79, 0.85, and 0.70 in women (p trend = 0.01) and 1.0, 0.87, 0.87, and 0.82 in men (p trend = 0.16). We found no association between dietary Mg intake and incident hypertension. These associations were attenuated after the addition of baseline systolic blood pressure to the models. CONCLUSIONS: This study suggests that low Mg may play a modest role in the development of hypertension.
Authors: Rebecca B Costello; Ronald J Elin; Andrea Rosanoff; Taylor C Wallace; Fernando Guerrero-Romero; Adela Hruby; Pamela L Lutsey; Forrest H Nielsen; Martha Rodriguez-Moran; Yiqing Song; Linda V Van Horn Journal: Adv Nutr Date: 2016-11-15 Impact factor: 8.701
Authors: Z Ulger; S Ariogul; M Cankurtaran; M Halil; B B Yavuz; B Orhan; G O Kavas; P Aribal; S Canlar; D S Dede; N Ozkayar; O Akyol Journal: J Nutr Health Aging Date: 2010-12 Impact factor: 4.075
Authors: Lin Li; Elani Streja; Connie M Rhee; Rajnish Mehrotra; Melissa Soohoo; Steven M Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh Journal: Am J Kidney Dis Date: 2015-07-14 Impact factor: 8.860
Authors: Sally N Adebamowo; Monik C Jiménez; Stephanie E Chiuve; Donna Spiegelman; Walter C Willett; Kathryn M Rexrode Journal: Stroke Date: 2014-08-12 Impact factor: 7.914
Authors: Adela Hruby; Christopher J O'Donnell; Paul F Jacques; James B Meigs; Udo Hoffmann; Nicola M McKeown Journal: JACC Cardiovasc Imaging Date: 2013-11-27
Authors: Jeffrey R Misialek; Faye L Lopez; Pamela L Lutsey; Rachel R Huxley; James M Peacock; Lin Y Chen; Elsayed Z Soliman; Sunil K Agarwal; Alvaro Alonso Journal: Circ J Date: 2012-10-06 Impact factor: 2.993
Authors: Tetsuya Ohira; James M Peacock; Hiroyasu Iso; Lloyd E Chambless; Wayne D Rosamond; Aaron R Folsom Journal: Am J Epidemiol Date: 2009-04-16 Impact factor: 4.897
Authors: Lina J Leurs; Leo J Schouten; Margreet N Mons; R Alexandra Goldbohm; Piet A van den Brandt Journal: Environ Health Perspect Date: 2009-10-26 Impact factor: 9.031